Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia

2 Sept 2005

Abstract excerpt

The great majority of patients with type III hyperlipidemia (type III HLP) are homozygous for the epsilon2 allele of the APOE gene. However, only about 10% of epsilon2 homozygotes develop type III HLP, and it has been proposed that additional genetic factors are required for the development of the condition. The frequency of two polymorphisms in the APOA5 gene, -1131T>C and S19W, has been determined in 72...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol and Lipid Metabolism
Share to Diabetes Treatment and Management
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16143024
DOI: 10.1111/j.1399-0004.2005.00510.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemiaPMID 16143024Read ↗

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.Semantic proximity Read ↗

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.Semantic proximity Read ↗

APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.Semantic proximity Read ↗

Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians.Semantic proximity Read ↗

Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.Semantic proximity Read ↗

-1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.Semantic proximity Read ↗

The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.Semantic proximity Read ↗

Apolipoprotein A5 in health and disease.Semantic proximity Read ↗

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.Semantic proximity Read ↗

The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.Semantic proximity Read ↗

Mutations of the apolipoprotein A5 gene with inherited hypertriglyceridaemia: review of the current literature.Semantic proximity Read ↗

Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.